What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience

Uterine serous carcinoma accounts for 3–10% of endometrial cancers, but it is the most lethal histopathological subtype. The molecular characterization of endometrial carcinomas has allowed novel therapeutic approaches for these patients. We undertook a retrospective analysis of patients with uterin...

Full description

Bibliographic Details

Published in:	Current Oncology
Main Authors:	Michalis Liontos, Anna Svarna, Charalampos Theofanakis, Oraianthi Fiste, Angeliki Andrikopoulou, Maria Kaparelou, Konstantinos Koutsoukos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios Athanasios Dimopoulos, Flora Zagouri
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Subjects:	cancer endometrial p53 abnormal expression survival
Online Access:	https://www.mdpi.com/1718-7729/28/6/410